TPO and type 1 diabetes mellitus: The data of this study show that treatment of euthyroid nongoitrous patients with T1DM and AIT leads to stabilization of anti-TPO levels and decrease of anti-TG titers and thus, with an increase of fT4 levels, protects the thyroid gland against further deterioration of thyroid function.